AR420626
Pharmaceutical compound
From Wikipedia, the free encyclopedia
AR420626 is an experimental drug which acts as a reasonably potent and highly selective agonist for the free fatty acid receptor FFAR3 (GPR41).[1][2] It has been used to research the role of FFAR3 in various disease processes such as diabetes,[3] asthma,[4] eczema[4] and some forms of cancer,[5] as well as regulation of gastrointestinal hormone release.[6]
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C21H18Cl2N2O3 |
| Molar mass | 417.29 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Further reading
- Said H, Akiba Y, Narimatsu K, Maruta K, Kuri A, Iwamoto KI, et al. (August 2017). "FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats". Digestive Diseases and Sciences. 62 (8): 1944–1952. doi:10.1007/s10620-017-4600-4. PMC 5511769. PMID 28523577.
- Yoshioka Y, Tachibana Y, Uesaka T, Hioki H, Sato Y, Fukumoto T, et al. (June 2022). "Uts2b is a microbiota-regulated gene expressed in vagal afferent neurons connected to enteroendocrine cells producing cholecystokinin". Biochemical and Biophysical Research Communications. 608: 66–72. Bibcode:2022BBRC..608...66Y. doi:10.1016/j.bbrc.2022.03.117. hdl:20.500.14094/90009216. PMID 35390674.